BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Press Releases

  SAB BIO to Participate in Upcoming Investor Conferences

  January 31, 2025

   · 

  3 min read
• Press Releases

  OKYO Pharma Announces Chairman and CEO Acquire Shares

  January 31, 2025

   · 

  1 min read
• 

  Earnings

  Novartis Eyes More Bolt-On Deals in 2025 as Q4 Earnings Easily Beat Consensus

  Novartis was among the most prolific pharma dealmakers in 2024, a trend that it expects to continue with more bolt-on deals this year to set up for sustainable long-term growth.

  January 31, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Government

  RFK Jr. Again Faces Scrutiny Over Vaccines on Day 2 of Confirmation Hearing

  Senators on the Health, Education, Labor and Pensions committee were critical of Kennedy’s long history as an anti-vaccine campaigner.

  January 31, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Venture capitalists

  Blackstone Launches New $5B+ Fund for Life Sciences

  Blackstone joins other big investors such as ARCH Venture Partners and Bain Capital Life Sciences in pumping billions of dollars into the industry.

  January 31, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• Press Releases

  Y-mAbs Presents Translational Pharmacokinetics of GD2-SADA from Pretargeted RIT Platform at the SNMMI Mid-Winter and ACNM Annual Meeting

  January 31, 2025

   · 

  7 min read
• Press Releases

  23andMe Launches New Genetic Report on Osteoporosis

  January 31, 2025

   · 

  5 min read
• Press Releases

  Revance Stockholders Urged to Tender Their Shares in Support of Crown Transaction by the February 4th Deadline

  January 31, 2025

   · 

  9 min read
• Press Releases

  AbbVie Reports Full-Year and Fourth-Quarter 2024 Financial Results

  January 31, 2025

   · 

  27 min read
• 

  Approvals

  Axsome’s Migraine Medicine Clears FDA Bar

  The approval of Axsome Therapeutics’ Symbravo for migraine with or without aura came alongside the greenlight for Vertex’s non-opioid treatment Journavx.

  January 31, 2025

   · 

  2 min read

   · 

  Tristan Manalac